Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2400-2406, November 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fidler, I. J.
Right arrow Articles by Montgomery, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fidler, I. J.
Right arrow Articles by Montgomery, P. C.

Effects of L-Asparaginase on Lymphocyte Surface and Blastogenesis1

Isaiah J. Fidler and Paul C. Montgomery

School of Dental Medicine and Center for Oral Health Research, University of Pennsylvania, Philadelphia, Pennsylvania 19104

L-Asparaginase is immunosuppressive, inhibiting both the cellular and humoral responses, as well as the concanavalin A-and/or phytohemagglutinin-induced blastogenesis of lymphocytes. However, its mechanism of action is presently unclear. This study dealt with the enzyme effects on the lymphocyte surface leading to interference with the binding of concanavalin A. The mitogen was labeled with 125I and added to lymphocyte cultures prior to or following incubation with L-asparaginase.

The data permitted the following conclusions. L-Asparaginase treatment prior to introduction of mitogen reduced the capacity of the lymphocyte to bind concanavalin A. Enzymatic treatment of lymphocytes 90 min after the introduction of mitogen did not influence this binding. Addition of L-asparagine, L-glutamine, and aspartic acid did not reverse the inhibitory effects of the enzyme. The decrease in mitogen binding (20%) led to a 95% decrease in subsequent DNA synthesis. Mitogen binding to receptors on lymphocytes precedes their subsequent stimulation. It appears that the decrease of mitogen binding by L-asparaginase results from an alteration on the lymphocyte surface. Any such alteration by the enzyme could account for its immunosuppressive activity.

1 Supported by USPHS Research Grants CA 12456 and DE 02623.

Received 5/19/72. Accepted 7/28/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.